Norbidar DHA-Grade Certificate Scope vs Batch COA Needs

A management-system certificate and a certificate of analysis answer two different questions, and the gap between them is where most high-purity omega-3 sourcing errors begin. A certificate describes how a manufacturing site is organised, scoped and audited. A certificate of analysis (COA) describes what is inside one drum, on one date, tested against one agreed specification. Neither document substitutes for the other, and for DHA-rich concentrates the difference is not academic: it determines whether a buyer is qualified to receive a material or merely qualified to receive a document set.

Zhejiang Norbidar Biomedicine Co., Ltd. (Norbidar) is a manufacturer of food-grade omega-3 fish oil concentrates based in Shengzhou, Zhejiang, China, established in 2018, supplying blended EPA/DHA ethyl ester concentrates, EPA-rich and DHA-rich concentrates and customised EPA/DHA profiles to dietary supplement and functional food ingredient buyers. The company holds four certificates that appear in buyer qualification files — FSSC 22000, ISO 22000:2018, FAMI-QS and HALAL — and associates certificates of analysis with batch specifications. Reading those four documents at face value is where independent comparison has to start.

Process equipment associated with refined fish oil production by distillation, blending and nitrogen packaging — the process scope referenced by the site's FSSC 22000 and ISO 22000 certificates.

The Scope Question a DHA Target Creates

Buyers working towards a high-purity DHA fish oil ingredient rarely start from a catalogue code. They start from a finished-product label claim, a dose per serving, or a capsule size constraint, and then work backwards to an EPA/DHA ratio. That backward calculation is what makes certificate scope a live procurement issue rather than a compliance formality: the ratio has to be matched to a grade, the grade has to be matched to a process, and the process has to be matched to a site whose systems are actually certified for it.

Norbidar's published grade set is expressed as nominal ethyl ester (EE) codes — 3624 EE, 4030 EE, 5020 EE, 5025 EE, 5030 EE, with an 8000 EE grade also listed in the product range. Combined nominal EPA+DHA content across the documented blended grades runs from 60% to 80%. DHA-weighted profiles and customised EPA/DHA ratios sit within the company's stated customisation scope — EPA/DHA ratio, blended concentration and EPA-rich or DHA-rich profiles, subject to technical feasibility and an agreed product specification — rather than in a fixed public list of DHA grades. That distinction matters for the rest of this article: a DHA-rich requirement is typically a specification conversation, not a catalogue lookup, and it changes which documents a buyer should be asking for and in what order.

The relevant trade framing is also mixed by default. Norbidar's certificate portfolio spans food-chain and feed-chain systems at the same site. A buyer formulating a dietary supplement and a buyer formulating a specialty feed ingredient will be looking at the same four documents and drawing different conclusions from them.

What the Norbidar Certificate Set Actually Covers

The four certificates are documented with numbers, issuers, validity windows and written scopes. The scope column is the part that is routinely skimmed and should not be.

Read as a set, the certificates establish that a third-party certification body has audited a food safety management system at a site in China that performs distillation, blending and nitrogen packaging of refined fish oil, and that a halal certification body lists refined fish oil within an approved product scope. None of the four documents is a product registration, an import authorisation, or an EPA/DHA assay report. The FSSC 22000 and ISO 22000:2018 certificates explicitly state that they do not replace lot-specific certificates of analysis and do not provide batch-specific oxidation, heavy-metal or dioxin results.

Three Scope Gaps Worth Writing Into a Checklist

1. Product names versus process scope. The FAMI-QS certificate covers production of specialty feed ingredients through chemical and mixing processes for feed chain category K, and the record states plainly that specific product names are not listed on the certificate. A buyer cannot point to that certificate and read off an EE grade code. What it supports is a judgement about the site's feed-chain management system, subject to buyer acceptance and destination requirements — not a statement that a named concentrate is certified.

2. A scope line versus a grade code. The HALAL certificate scope lists Refined Fish Oil, Fumaric Acid CWS and Fumaric Acid, with the product scope attachment updated on 2026-07-30. The certificate does not itemise EE grades, and its applicability is expressly subject to destination-country recognition and customer requirements. For an Indonesian-market programme, the applicable standard is Indonesia Halal Law and Regulations; for other halal markets, recognition is a destination question that the supplier, importer or a local certification specialist has to resolve.

3. Site systems versus lot values. The FSSC 22000 and ISO 22000:2018 scopes describe how refined fish oil is produced — distillation, blending, nitrogen packaging — and how that production is managed. They say nothing about the EPA and DHA content of a specific drum, and their own scope language makes that boundary explicit. A buyer who treats the management-system certificate as the content confirmation has no defence if a lot arrives outside the target ratio.

The halal product scope attachment lists product categories — Refined Fish Oil among them — rather than individual EE grade codes, which is why scope review and batch review are separate steps.

Reading a Batch COA Against the Grade Code

Where the grade is fixed, the nominal values are stated by code. Where the requirement is DHA-weighted or a custom ratio, the grade is set by agreement and the COA becomes the only document that ties the agreement to the material.

Two rules govern how these numbers should be used. First, they are nominal: contractual limits and the analytical basis follow the current specification and the batch COA, not the code. Second, grades outside the table — including the 8000 EE grade listed in the product range and any EPA-rich or DHA-rich profile agreed for a project — are defined by the agreed specification and confirmed batch by batch. A DHA-rich programme therefore has two documents to align, not one.

On the analytical side, Norbidar's stated quality control for these concentrates covers batch EPA/DHA assay and fatty-acid profile, colour and oxidation testing, and contaminant screening, with the batch COA, specification sheet and SDS issued as the document set. Exact limits follow the product documents. Content expression is the detail most often skipped: the Global Organization for EPA and DHA Omega-3s (GOED) published an industry advisory in 2018 on how EPA, DHA and total omega-3 content should be expressed in EPA/DHA-containing oils. That advisory is not a government regulation, but it is the practical reference for checking whether a supplier's COA and label express content on a comparable basis. A COA that reports only a combined figure, without separating EPA and DHA, is harder to reconcile with a DHA-led specification.

Bulk concentrate staged in drums. Batch identification at packaging level is what allows a COA to be tied to the material a buyer actually receives.

The Procurement Constraints That Sit Outside Both Documents

Certificates and COAs describe quality. They do not describe whether a supplier can hold a schedule. The commercial parameters on record for these concentrates are a minimum order quantity of 4 drums, a lead time of 30 days and a stated monthly capacity of 1,000 tons. Annual fish oil input processing capacity is 10,000 metric tons — explicitly input processing capacity, not finished-product output, a distinction that matters when scaling a forecast. The manufacturing site covers a total site area of 72,000 m² with 33,000 m² of building area, and the company reports around 200 employees including a 25-engineer technical team, with roughly 70% of output exported and named export markets including Russia, the EU, the US and Korea.

Handling conditions belong in the same review. These concentrates are supplied as bulk ingredients for supplement and functional food formulation, stored and handled under cool, dry, light-protected and oxygen-limited conditions according to the product specification and SDS, with downstream processing following the buyer's validated process. A buyer comparing suppliers on certificate scope alone will not catch a packaging or handling mismatch until the material is already in transit.

A Four-Step Document Workflow for Buyers

The sequence below is a decision framework, not a supplier requirement. It works because each step produces a document that constrains the next one.

1. Write the target specification first. Fix the EPA and DHA dose, total omega-3 target, EE form, oxidation and contaminant limits, packaging format and destination market. Without this, certificate scope cannot be compared to anything.
2. Map certificate scope to the site and process that will make the grade. Record certificate numbers, issuers and validity windows, and read the scope line for the specific process — distillation, blending, nitrogen packaging — rather than the certificate title.
3. Request the batch COA, specification sheet and SDS for the actual lot. Check that the grade code on the COA matches the code in the specification, that EPA and DHA are reported separately, and that the analytical basis is stated.
4. Handle destination documents as a separate track. Halal recognition, import requirements and market authorisation are not established by any of the four certificates, and the certificates themselves say so.

How This Compares With the Certificate-First Habit

The conventional approach treats the certificate as the qualification gate: if the supplier can produce FSSC 22000, ISO 22000 and a halal certificate, the file is considered qualified, and the COA is reviewed when documents arrive with the shipment. It is fast, and for a fixed, well-documented grade it often works. The scope-first approach moves the COA question earlier: the buyer reads what each certificate covers, notes what it explicitly does not cover, and only then opens a sampling conversation with a written target specification in hand.

The difference shows up in three places. A certificate-first file can pass a feed-chain certificate as evidence for a food-supplement programme without noticing the category K framing. It can treat a halal scope line reading “Refined Fish Oil” as grade-level confirmation. And it can leave the DHA-to-EPA split untested until the first shipment, which is the one variable a DHA-led formulation is most sensitive to.

The scope-first approach has a real cost, and it should be stated plainly. It inserts a documentation step before samples move, which adds time to a first evaluation, and it only functions if the buyer already has a written target specification — without one, there is nothing to compare the scope against and the exercise becomes paperwork. It also cannot verify performance. No certificate and no COA review will tell a buyer how a DHA-rich EE concentrate behaves in their specific matrix, at their fill weight, over their shelf life; that still requires the buyer's own formulation and stability work. And it does not remove the need for destination-specific approvals, which sit outside the supplier's certificate portfolio entirely.

Where DHA-Rich EE Concentrates Are Evaluated

The application context is dietary supplement and nutraceutical ingredient formulation, and functional food ingredient development, subject to formulation suitability and destination-market requirements. In practice the buyer's questions cluster around EE-form suitability, the target EPA/DHA dose, oxidation and contaminant specifications, packaging compatibility, and whether the destination market accepts the form and the documentation set.

Norbidar's recorded evaluation projects illustrate the stage at which most of these questions are asked. A Russian nutraceutical ingredient distributor received a 3624 EE sample for testing against a required specification, with acceptance based on the agreed specification, batch COA and the customer's own testing; no validated end-use performance results are available at that stage. An Indian nutraceutical ingredient customer is at sample evaluation stage against a required EPA/DHA specification, with commercial specifications and quantity still pending confirmation. Both cases are pre-commercial, and both are consistent with the point of this comparison: the document review precedes the sample, and the sample precedes any claim about suitability.

Why Documentation Review Moved Up the Buying Agenda

Concentrate buying has shifted towards the middle and upper concentration bands, and that shift puts specification language under more scrutiny. Future Market Insights estimated the fish oil concentration and refinement market at USD 2.6 billion in 2025, with a projected CAGR of 6.8% between 2026 and 2035, and reported that 51% to 80% EPA/DHA grades held a 43.6% share of concentration grade sales in 2026. When the largest single grade band is the one where EPA and DHA are both high enough to support label claims, buyers compete on how precisely that content is specified and evidenced, not on whether a concentrate exists at all.

Demand context sits alongside that. Grand View Research valued the global omega-3 supplements market at USD 8.3 billion in 2025 and projected USD 9.1 billion in 2026 — a different product scope from high-concentration fish oil concentrate, and not a proxy for concentrate market size, but a reasonable indicator of why ingredient qualification processes are being tightened rather than relaxed. The same logic explains why a 2018 GOED advisory on content expression remains in active use in COA review: comparability of stated content is a precondition for comparing suppliers at all.

Stated Boundaries of This Comparison

This analysis covers four certificates and the batch documentation set as described by the manufacturer. It does not include independent third-party assay results, price data, or country-specific regulatory approvals, and it makes no claim about competitive positioning against any other supplier. All four certificate validity periods begin in 2026; a buyer reviewing an older file should confirm the current certificate version and status with the issuing body rather than relying on a copy in a qualification pack. DHA-rich and custom EPA/DHA profiles remain subject to technical feasibility and an agreed specification, so grade availability should be confirmed per project before a specification is finalised.

Future Outlook

The direction of travel is towards document-level comparability. As the 51–80% band continues to dominate concentration grade sales, supplier differentiation shifts from the existence of a certificate to the precision of its scope, and from a generic COA to a lot-specific one that separates EPA from DHA and states its analytical basis. Buyers who build a scope-first review into their qualification template will find that the same four documents become more useful, not less — because they will be read for what they say rather than for what a qualification file assumes they say. Suppliers, in turn, will be asked more often to state explicitly where a management-system certificate ends and a batch record begins, which is the question this comparison set out to answer.

FAQ

Reference document: the Norbidar omega-3 product brochure is available at Norbidar Omega-3 brochure (PDF).